Products per Cell Type Cytokines & Growth Factors Serum-free Media
CellGenix® GMP rh TGF-beta1
CellGenix® Preclinical rh TGF-beta1

CellGenix® rh TGF-β1

GMP and Preclinical grade

CellGenix® Recombinant Human TGF-β1 reliably promotes the expansion of induced pluripotent stem cells (iPSC), embryonic stem cells (ESC), mesenchymal stem cells (MSC) as well as regulatory T cells (Tregs). It also stimulates the differentiation of T cells into Tregs.

CellGenix® Recombinant Human TGF-β1 is produced using a human amniocyte cell line (CAP®). By using the CAP® technology we are able to produce this difficult to express glyco-protein with authentic human post-translational modifications. These human post-translational modifications are not accessible by bacterial expression.

GMP Grade

CellGenix® GMP Recombinant Human TGF-β1 is produced following applicable GMP guidelines and allows for the safe use in accordance with USP Chapter <1043>, Ph. Eur. General Chapter 5.2.12 and ISO 20399:2022.

Our GMP cytokines are provided with documented evidence of purity, potency, consistency and stability. In combination with our expert regulatory and technical support this will help simplify your raw material qualification and validation efforts.

Preclinical Grade

Designed to meet the demands of translational research, CellGenix® preclinical cytokines are ideal to bridge the gap between the lower quality of research grade and the higher costs of GMP grade materials.

Name
CellGenix® Recombinant Human Transforming Growth Factor-beta 1
Source
CAP® cell line
Formulation
Lyophilized
ANIMAL-DERIVED COMPONENT-FREE
ADCF level 1
CellGenix® GMP rh TGF-β1
amount
Order Number
50  µg
1026-050
CellGenix® Preclinical rh TGF-β1
amount
Order Number
50  µg
1426-050
Product Documents
How to Order
Inquiries
Buy Now

CellGenix® rh TGF-β1

Features

  • Native folding & glycosylation: expressed in human CAP® cells
  • Safe and ADCF: CAP® cell line extensively characterized and tested for viruses
  • Compliant to USP <1043> and Ph. Eur. 5.2.12, ISO 20399:2022 (GMP)
  • FDA Drug Master File available (GMP)

GMP & Preclinical Grade

  • Seamless transition from preclinical development to ATMP manufacturing

Highest GMP Quality Standard

  • High lot-to-lot consistency – save time and costs on revalidations
  • Performance reliability – rely on consistent product performance
  • Highest purity – ensure the safety of your ATMP
  • Extremely low endotoxin levels – improve safety and reproducibility
  • Expert regulatory & technical support – rely on experience

Read more about our GMP Quality

 

Safe │ GMP Compliant │ Reliable

Applications

Transforming Growth Factor-beta 1 (TGF-β1) is a member of the growth factor beta superfamily and plays a role in various cellular functions like cell differentiation, proliferation and apoptosis. It is secreted by most immune cells and especially interacts with T cells, B cells, macrophages and monocytes.

TGF-β1 is used in the cell and gene therapy space to promote expansion of iPSC, ESC, MSC and Tregs.

Technical Details

Source
Expressed in CAP® cell line
Description

Human Transforming Growth Factor-beta 1, accession # PO1137, Ala279-Ser390

Formulation

Lyophilized from a 0.2 µm-filtered solution containing 1% Mannitol

The production cell line was derived from an extensively characterized human amniocyte cell line (CAP®).
CAP® is a registered trademark of CEVEC Pharmaceuticals GmbH, Germany.

  Preclinical GMP
Starting Material

CAP® MCB characterized according to ICH Guidelines Q5A and Q5D
Biologics Master File (BB-MF) for the originating CAP® cell bank available

CAP® MCB characterized according to ICH Guidelines Q5A and Q5D
Biologics Master File (BB-MF) for the originating CAP® cell bank available
Molecular weight 25.6 kDa per homodimer 25.6 kDa per homodimer
Purity ≥ 95% as determined by SDS-PAGE ≥ 97% as determined by SDS-PAGE
Activity

≥ 9 x 106 IU/mg, calibrated against NIBSC #89/514
Measured in a cell proliferation assay using a TGF-β1-dependent cell line, HT2 clone A5E

 

≥ 9 – 36 x 106 IU/mg, calibrated against NIBSC #89/514
Measured in a cell proliferation assay using a TGF-β1-dependent cell line, HT2 clone A5E

Batch specific activity on CoA
Endotoxin level ≤ 10 EU/mg ≤ 10 EU/mg
Intended use Intended for preclinical ex vivo use. Not intended for therapeutic use. For further manufacturing use.

Handling Instructions

Reconstitution

Recommended in sterile water to a final concentration of 250 µg/ml.

Shipment

Ambient temperature. Please refer to our Technote Shipment of CellGenix® Preclinical and GMP Cytokines at Ambient Temperatures.

Expiry

GMP: ≥ 6 months from date of shipping
Preclinical: 3 years from date of shipping 

Please refer to Certificate of Analysis for the exact expiry date.

Storage & Stability

Store lyophilized cytokine at -20°C to -80°C.

Avoid repeated freeze/thaw cycles.

Documents

Data

CellGenix® GMP rh TGF-β1 has an activity of 9 – 36 x 106 IU/mg

The activity of GMP rh TGF-β1 was measured in a cell proliferation assay using the TGF-dependent cell line HT2-clone A5E. It was calibrated against the WHO International Standard NIBSC #89/514.

You can find the batch specific activity on the Certificate of Analysis (CoA).

Regulatory Support

We offer the following to assist you with your regulatory approval process:

  • Comprehensive documentation (e.g. DMFs, Regulatory Support Files, Certificates of Origin)
  • Outstanding QC support (e.g. extensive stability data)
  • The possibility to audit our production site
  • Detailed batch specific test results on our Certificates of Analysis
  • Change notifications prior to relevant changes

Customized solutions can be provided to meet special compliance needs. Contact our Regulatory Support Team for all your regulatory requests & questions:

Phone:     +49 761 88 88 9-0
Email:      regulatorysupport-freiburg@sartorius.com

 

In order to stay up-to-date and help improve regulatory guidance we are actively involved in many of the regulatory initiatives and discussions. We were amongst others actively involved in the discussions for the setup of Ph. Eur. General Chapter 5.2.12 and ISO 20399:2022.

 

Regulatory Resources

  • TSE certificate (available on request)
  • Regulatory Support File (available on request)
  • Request a DMF Letter of Authorization (USA only)

Related Products

Cytokines & Growth Factors

Product Name
Quality Grade
Application
CellGenix® rh Activin A
GMP | Preclinical
ESC/iPSC
CellGenix® rh FGF-2
GMP | Preclinical
MSC, ESC/iPSC, Chondrocytes
CellGenix® rh IL-2
GMP | Preclinical
T cells, NK cells, CIK cells
CellGenix® rh OSM
Preclinical
ESC/iPSC
CellGenix® rh PDGF-BB
GMP | Preclinical
Chondrocytes, MSC

Serum-free Media

Product Name
Quality Grade
Application
CellGenix® GMP TCM
GMP
T cells
© 2024 Sartorius CellGenix GmbH

We are happy to send the requested document to your email address:

Would you like to be the first to receive the latest news, documents, product updates and tips from Sartorius CellGenix?


You can unsubscribe at any time by sending an email to info@cellgenix.com or by using the unsubscribe option at the bottom of our newsletters and emails.
×

We are happy to send the requested document to your email address:

Would you like to be the first to receive the latest news, documents, product updates and tips from Sartorius CellGenix?


You can unsubscribe at any time by sending an email to info@cellgenix.com or by using the unsubscribe option at the bottom of our newsletters and emails.
×

We are happy to send the requested document to your email address:

Would you like to be the first to receive the latest news, documents, product updates and tips from Sartorius CellGenix?


You can unsubscribe at any time by sending an email to info@cellgenix.com or by using the unsubscribe option at the bottom of our newsletters and emails.
×

We are happy to send the requested document to your email address:

Would you like to be the first to receive the latest news, documents, product updates and tips from Sartorius CellGenix?


You can unsubscribe at any time by sending an email to info@cellgenix.com or by using the unsubscribe option at the bottom of our newsletters and emails.
×

We are happy to send the requested document to your email address:

Would you like to be the first to receive the latest news, documents, product updates and tips from Sartorius CellGenix?


You can unsubscribe at any time by sending an email to info@cellgenix.com or by using the unsubscribe option at the bottom of our newsletters and emails.
×

Where are you located?

Note: You have to select a country.